More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$80287511
P/E ratio
13.5
Dividend yield
--
Expense ratio
0.76%
Beta
1.025221
Previous close
$22.54
Today's open
$22.79
Day's range
$22.28 - $23.33
52 week range
$13.96 - $43.94
Industries
Health
After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS
Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) posted a 17% gain in 2025, but that masks the real story.
24/7 Wall Street • Jan 2, 2026

CNBS: New Buy Rating On Cannabis ETF, Stoked By Positive Regulatory Trend
Amplify Seymour Cannabis ETF (CNBS) is positioned for upside as U.S. cannabis reclassification to Schedule III appears likely, marking a key industry milestone. CNBS exhibits extreme volatility, warranting only a small (1-3%) portfolio allocation; call options are not attractive due to high premiums. Current CNBS valuations—12x trailing earnings and 3x sales—are reasonable for a growth sector anticipating regulatory tailwinds.
Seeking Alpha • Dec 18, 2025

Cannabis ETF (CNBS) Hits New 52-Week High
CNBS Cannabis ETF climbs to a 52-week high, fueled by rescheduling optimism and potential further gains.
Zacks Investment Research • Dec 18, 2025

Cannabis ETFs: This Imminent Trigger Could Lead To A Definitive Repricing Of Assets
I recommend buying cannabis sector ETFs. Recent news suggests imminent U.S. regulatory easing, potentially reclassifying marijuana and unlocking significant sector value. Current MJ ETF price/sales is 1.5x; I conservatively project a move to 2.5x, implying 66% upside. Key risks include regulatory uncertainty, sector profitability challenges, and historical underperformance post-IPOs.
Seeking Alpha • Dec 17, 2025

6 Top-Performing ETF Areas of Last Week
Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.
Zacks Investment Research • Dec 17, 2025

Cannabis ETFs Soar Double-Digits on Friday: Here's Why
Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.
Zacks Investment Research • Dec 15, 2025

Cannabis stocks rally on reports Pres. Trump will sign executive order reclassifying marijuana
'Fast Money' trader Tim Seymour talks the jump in cannabis stocks on reclassification rumors.
CNBC Television • Dec 12, 2025

5 ETFs to Watch as Restrictions on Marijuana Set to Ease
Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.
ETF Trends • Dec 12, 2025

'Green Wednesday': A high holiday for cannabis before Thanksgiving
Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. Brandon Gomez unpacks the new buzzy trend for an age old tradition.
CNBC Television • Nov 26, 2025

Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror
It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this year's thematic ETF rearview mirror.
ETF Trends • Sep 10, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Amplify Seymour Cannabis ETF commission-free¹. Build wealth for the long term using automated trading and transfers.